A new case report shows that a quick, bedside ultrasound test can detect possible brain abscesses by identifying characteristic lesions. While not a definitive diagnostic tool, this low-cost method could help emergency departments, especially in resource-limited settings, triage patients faster for advanced scans and crucial surgery.

The rational design of platinum-based electrocatalysts with optimized metal-support electronic interactions remains a fundamental challenge in achieving atom-efficient hydrogen evolution reaction (HER).

Scientists have developed an innovative "sulfur-for-oxygen exchange" method to synthesize a porous Fe₂(MoO₄)₃/CoMoO₄ heterojunction electrocatalyst. This material demonstrated exceptional oxygen evolution reaction (OER) performance, requiring only 244 mV of overpotential to achieve a current density of 10 mA·cm⁻² – significantly outperforming commercial benchmarks. Furthermore, it exhibited outstanding stability, operating continuously for over 100 hours. This breakthrough paved the way for scalable, cost-effective green hydrogen production.

A novel fiber optic sensing platform captures real-time bubble dynamics during hydrogen evolution, revealing how bubble growth and detachment impact catalyst performance. This breakthrough bridges interfacial gas behavior with electrochemical efficiency, offering new strategies for green hydrogen optimization.

Researchers from Wroclaw Medical University investigated why some transplanted kidneys deteriorate despite treatment, focusing on a type of rejection called microvascular inflammation (MVI). This form of injury, now highlighted in the updated Banff 2022 Classification, is difficult to detect without biopsy and is often not accompanied by classic markers such as anti-HLA antibodies. To address this diagnostic gap, the team examined the role of non-HLA antibodies, particularly those targeting the angiotensin II type 1 receptor (AT1R).

In a study of 167 transplant recipients, MVI was significantly more common in patients with elevated AT1R antibody levels. Using advanced analytical methods, including artificial intelligence, the researchers identified that only high AT1R titers (>12 U/ml) meaningfully increased the risk of MVI. This suggests that non-HLA antibodies may contribute to graft injury in cases where traditional tests remain negative.

The findings open a path toward developing a more comprehensive, minimally invasive immunological profile to support early diagnosis of rejection. According to the authors, AI-assisted tools may become an essential part of transplant medicine, helping clinicians detect risk sooner and prolong the lifespan of transplanted kidneys.